Try our Advanced Search for more refined results
Sumitomo Pharma Co. Ltd.
-
Order | Filed: May 31, 2024 | Entered: May 31, 2024 United States of America et al. v. Sumitomo Pharma America, Inc.
Qui Tam (31 U.S.C. § 3729(a)) | Minnesota
Order on Motion for Leave to File Reply/Surreply
(Text-Only) ORDER: Plaintiff's Motion for Leave to File Supplemental Brief 162 is DENIED. The motions 142 147 have been fully briefed, argued, and taken under advisement. Ordered by Judge Eric C. Tostrud on 5/31/2024. (RMM)
-
Motion | Filed: May 30, 2024 | Entered: May 30, 2024 United States of America et al. v. Sumitomo Pharma America, Inc.
Qui Tam (31 U.S.C. § 3729(a)) | Minnesota
Leave to File Reply/Surreply
MOTION for Leave to File Reply/Surreply filed by Scott Louderback. (Goulder, Jeffrey)
-
Misc | Filed: May 28, 2024 | Entered: May 28, 2024 United States of America et al. v. Sumitomo Pharma America, Inc.
Qui Tam (31 U.S.C. § 3729(a)) | Minnesota
Transcript Request
TRANSCRIPT REQUEST for a 30-Day Transcript for a COPY OF TRANSCRIPT 158 Motion Hearing,,, to Court Reporter Tim Willette. (Driscoll, Devin)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login